PLCB4

Chr 20ADAR

phospholipase C beta 4

Also known as: ARCND2, ARCND2A, ARCND2B, PI-PLC

The protein encoded by this gene catalyzes the formation of inositol 1,4,5-trisphosphate and diacylglycerol from phosphatidylinositol 4,5-bisphosphate. This reaction uses calcium as a cofactor and plays an important role in the intracellular transduction of many extracellular signals in the retina. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2010]

Primary Disease Associations & Inheritance

Auriculocondylar syndrome 2AMIM #614669
AD
Auriculocondylar syndrome 2BMIM #620458
AR
397
ClinVar variants
57
Pathogenic / LP
0.00
pLI score
0
Active trials
Clinical SummaryPLCB4
🧬
Gene-Disease Validity (ClinGen)
auriculocondylar syndrome 2 · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

2 total gene-disease associations curated

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.32) despite low pLI — interpret in context.
📋
ClinVar Variants
57 Pathogenic / Likely Pathogenic· 194 VUS of 397 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Missense constrained — critical functional residues
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE — the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
0.45LOEUF
pLI 0.000
Z-score 5.55
OE 0.32 (0.230.45)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
3.57Z-score
OE missense 0.60 (0.550.65)
382 obs / 635.4 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≤ 0.35 = strong LoF constraint signal.0.32 (0.230.45)
00.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≤ 0.6 = fewer missense variants than expected by chance.0.60 (0.550.65)
00.61.4
Synonymous OE?Control metric — synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.0.99
01.21.6
LoF obs/exp: 25 / 77.8Missense obs/exp: 382 / 635.4Syn Z: 0.13

ClinVar Variant Classifications

397 submitted variants in ClinVar

Classification Summary

Pathogenic43
Likely Pathogenic14
VUS194
Likely Benign47
Benign90
Conflicting9
43
Pathogenic
14
Likely Pathogenic
194
VUS
47
Likely Benign
90
Benign
9
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
4
11
28
0
43
Likely Pathogenic
4
7
3
0
14
VUS
3
134
54
3
194
Likely Benign
0
10
16
21
47
Benign
0
8
73
9
90
Conflicting
9
Total1117017433397

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

PLCB4 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Gene2Phenotype Curations

PLCB4-related auriculocondylar syndrome

strong
ADUndeterminedAltered Gene Product Structure
Dev. DisordersSkeletal
G2P ↗
missense variantinframe deletioninframe insertion

Gene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org

OMIM — Genotype-Phenotype Relationships

1 OMIM entry

Auriculocondylar syndrome 2A

MIM #614669

Molecular basis of disorder known

Autosomal dominant

Auriculocondylar syndrome 2B

MIM #620458

Molecular basis of disorder known

Autosomal recessive
Clinical Literature
Landmark / reviewRecent case evidence
Key Publications
Landmark & review papers · by relevance
PubMed
Oncogenic signaling in uveal melanoma.
Park JJ et al.·Pigment Cell Melanoma Res
2018Review
Top 10 resultsSearch PubMed ↗
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →